Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MANCHESTER, NH--(Marketwire - Jun 22, 2012) - Boston Therapeutics, Inc. (OTCQB: BTHE) (OTCBB: BTHE) ("Boston Therapeutics" or "The Company"), a developer of complex carbohydrates to treat diabetes...
-
MANCHESTER, NH--(Marketwire - Jun 21, 2012) - Boston Therapeutics, Inc. (OTCQB: BTHE) (OTCBB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to...
-
MANCHESTER, NH--(Marketwire - Jun 14, 2012) - Boston Therapeutics, Inc. (OTCQB: BTHE) (OTCBB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to...
-
MANCHESTER, NH--(Marketwire - Jun 11, 2012) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes...
-
MANCHESTER, NH--(Marketwire - Jun 7, 2012) - Boston Therapeutics, Inc. (OTCQB: BTHE) (OTCBB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrates to treat diabetes...
-
MANCHESTER, NH--(Marketwire - Apr 18, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, today announced that it has received its first commercial purchase order...
-
MANCHESTER, NH--(Marketwire - Apr 10, 2012) - Boston Therapeutics, Inc. (BTHE) (OTCBB: BTHE), a developer of diabetes therapeutics, announced today no safety concerns from the interim data analysis...
-
MANCHESTER, NH--(Marketwire - Apr 6, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, announced today that it has launched a publicity campaign to increase...
-
MANCHESTER, NH--(Marketwire - Apr 2, 2012) - Boston Therapeutics Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, reviews the series of events that have led to the availability of its lead...
-
MANCHESTER, NH--(Marketwire - Mar 22, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that the Company's common stock was quoted on...